| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/23/2009 | US20090105207 Copper (1) Complex |
| 04/23/2009 | US20090105206 Copper Melphalan And Copper Tegafur As Anti-Tumor Agents |
| 04/23/2009 | US20090105205 Methods of treating disease states using antiangiogenic agents |
| 04/23/2009 | US20090105204 Therapeutic Uses for Aminosterol Compounds |
| 04/23/2009 | US20090105203 Compounds for treating viral infections |
| 04/23/2009 | US20090105202 Androsterone Derivatives and Method of Use thereof |
| 04/23/2009 | US20090105201 Pulmonary Pharmaceutical Formulations |
| 04/23/2009 | US20090105200 Combination therapy |
| 04/23/2009 | US20090105199 Oligomers of cholesterol, cholesterol sulphate and cholesterol esters and also drugs containing these |
| 04/23/2009 | US20090105198 estrone derivatives, used for the treatments of vasomotor symptoms, atrophic vaginitis, osteoporosis, breast and prostate cancers |
| 04/23/2009 | US20090105197 Use of Sodium Channel Blocking Compounds and Aspirin in Manufacturing Drugs for Producing Analgesia Synergistically in Mammals |
| 04/23/2009 | US20090105196 Use of creatine compounds to treat dermatitis |
| 04/23/2009 | US20090105194 Process for the production of a low molecular weight heparin |
| 04/23/2009 | US20090105193 Crosslinked compounds and methods of making and using thereof |
| 04/23/2009 | US20090105192 Glycosaminoglycans derived from k5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation |
| 04/23/2009 | US20090105191 Pharmaceutical and Dermatocosmetic Compositions Comprising Extract of Durio Zibenthinus |
| 04/23/2009 | US20090105190 Method for Producing Fucoidan, Fucoidan, and Fucoidan-Containing Composition |
| 04/23/2009 | US20090105189 Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same |
| 04/23/2009 | US20090105188 Compositions and Methods for Treating Necrotizing Enterocolitis |
| 04/23/2009 | US20090105187 Methods of treating lentivirus infection |
| 04/23/2009 | US20090105186 Beta-L-N4-Hydroxycytosine Deoxynucleosides and their use as Pharmaceutical Agents in the Prophylaxis or Therapy of Viral Diseases |
| 04/23/2009 | US20090105185 Nucleosides with anti-hepatitis B Virus activity |
| 04/23/2009 | US20090105184 Positron emission tomography probes for imaging immune activation and selected cancers |
| 04/23/2009 | US20090105183 Pharmaceutical composition containing decoy and method of using the same |
| 04/23/2009 | US20090105182 RNAi-MEDIATED INHIBITION OF STROMAL CELL-DERIVED FACTOR 1-RELATED TARGETS FOR TREATMENT OF NEOVASCULARIZATION-RELATED CONDITIONS |
| 04/23/2009 | US20090105181 Modulation of sodium channels by nicotinamide adenine dinucleotide |
| 04/23/2009 | US20090105180 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 04/23/2009 | US20090105179 Drug carriers |
| 04/23/2009 | US20090105178 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET-DERIVED ENDOTHELIAL CELL GROWTH FACTOR (ECGF1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/23/2009 | US20090105177 Modulation of diacylglycerol acyltransferase 1 expression |
| 04/23/2009 | US20090105176 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 04/23/2009 | US20090105175 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 04/23/2009 | US20090105174 Nucleic acids hybridizable to micro rna and precursors thereof |
| 04/23/2009 | US20090105173 Prevention and treatment of acute renal failure and other kidney diseases by inhibition of p53 by siRNA |
| 04/23/2009 | US20090105172 Stabilized Aptamers to PSMA and Their Use as Prostate Cancer Therapeutics |
| 04/23/2009 | US20090105171 Methods for Regenerating and Repairing Damaged Tissues Using Adrenomedullin |
| 04/23/2009 | US20090105169 Allele-specific silencing of disease genes |
| 04/23/2009 | US20090105168 Use Of HDAC And/Or DNMT Inhibitors For Treatment Of Ischemic Injury |
| 04/23/2009 | US20090105167 Predicting responsiveness to cancer therapeutics |
| 04/23/2009 | US20090105166 Novel lapachone compounds and methods of use thereof |
| 04/23/2009 | US20090105165 Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides |
| 04/23/2009 | US20090105164 Substituted indole-o-glucosides |
| 04/23/2009 | US20090105163 Conjugates of Immune Cell Specific Macrolide Compounds with Anti-Inflammatory Compounds for Improved Cellular Targeting of Anti-Inflammatory Therapy |
| 04/23/2009 | US20090105162 Substituted fused heterocyclic c-glycosides |
| 04/23/2009 | US20090105161 D-mannose contraceptives |
| 04/23/2009 | US20090105150 Angiotensin derivatives |
| 04/23/2009 | US20090105147 Deuterated etravirine |
| 04/23/2009 | US20090105143 Hiv fusion inhibitor peptides with improved biological properties |
| 04/23/2009 | US20090105139 Soluble HER2 and HER3 splice variant proteins, splice-switching oligonucleotides, and their use in the treatment of disease |
| 04/23/2009 | US20090105129 Combination therapy |
| 04/23/2009 | US20090105128 Cannabinoid receptor targeted agent |
| 04/23/2009 | US20090105125 Methods of Treating Fatty Liver Disease |
| 04/23/2009 | US20090105124 Heterocyclic modulators of tgr5 |
| 04/23/2009 | US20090105115 Polyamides for nucleic acid delivery |
| 04/23/2009 | US20090105088 Mutant bank |
| 04/23/2009 | US20090104677 Heteroaromatic Selective Inhibitors of Neuronal Nitric Oxide Synthase |
| 04/23/2009 | US20090104651 Screening process for antibacterial agents |
| 04/23/2009 | US20090104631 Psca: prostate stem cell antigen and uses thereof |
| 04/23/2009 | US20090104618 Diagnosing high grade ductal carcinoma (mammary glands) in situ (DCIS) by determining the level of psoriasin gene expression in a sample |
| 04/23/2009 | US20090104297 Herbal composition for treatment of infections caused by dermatophytes |
| 04/23/2009 | US20090104291 Water-dispersible nanoparticle which contains blood circulation promoter |
| 04/23/2009 | US20090104288 Compositions and methods for inhibiting a honey bee pathogen infection or controlling a hive infestation |
| 04/23/2009 | US20090104285 Methods and Compositions for Use in Treating Cancer |
| 04/23/2009 | US20090104283 Method for reducing the severity of neurological disorders |
| 04/23/2009 | US20090104281 Compositions Having a High Antiviral and Antibacterial Efficacy |
| 04/23/2009 | US20090104276 Faster absorption or hydrolysis, while preserving mechanical strength required for e.g. surgical sutures; also used to produce microspheres for use as an injectable composition or drug delivery carrier; copolymer of diglycolid acid, diethylene glycol, and a lactone |
| 04/23/2009 | US20090104273 Novel nifedipine compositions |
| 04/23/2009 | US20090104270 Film delivery system for tetrahydrolipstatin |
| 04/23/2009 | US20090104266 3-(2-dimethylaminomethylcy clohexyl)phenol retard formulation |
| 04/23/2009 | US20090104265 Polymorphs of N-(4-chloro-3-methyl-5-isoxazolyl) 2-[2-methyl-4,5-(methylenedioxy)phenylacetyl] thiophene-3-sulfonamide, sodium salt |
| 04/23/2009 | US20090104264 Controlled release solid preparation |
| 04/23/2009 | US20090104263 5-HT4 partial agonist pharmaceutical compositions |
| 04/23/2009 | US20090104262 Chlorthalidone combinations |
| 04/23/2009 | US20090104261 Treatment for Attention-Deficit Hyperactivity Disorder |
| 04/23/2009 | US20090104260 Compositions and methods for sirna inhibition of icam-1 |
| 04/23/2009 | US20090104259 Compositions and methods for sirna inhibition of angiogenesis |
| 04/23/2009 | US20090104256 Methods of Treating Pulmonary Disorders with Liposomal Amikacin Formulations |
| 04/23/2009 | US20090104255 Liposome Drug Delivery of Polycyclic, Aromatic, Antioxidant or Anti-Inflammatory Compounds |
| 04/23/2009 | US20090104254 Controlled Release Hydrogels |
| 04/23/2009 | US20090104247 Coating Designs For The Tailored Release Of Dual Drugs From Polymeric Coatings |
| 04/23/2009 | US20090104246 local administration of a combination of rapamycin and panzem for the treatment of vulnerable plaque |
| 04/23/2009 | US20090104244 Therapeutic agent-eluting medical devices having textured polymeric surfaces |
| 04/23/2009 | US20090104240 Dual Drug Formulations For Implantable Medical Devices For Treatment of Vascular Diseases |
| 04/23/2009 | US20090104230 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/23/2009 | US20090104212 Methods and systems for treating cell proliferation disorders using two-photon simultaneous absorption |
| 04/23/2009 | US20090104209 Methods of reducing a viral infection and kits therefore |
| 04/23/2009 | US20090104206 Bone microenvironment modulated migraine treatments |
| 04/23/2009 | US20090104201 Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis |
| 04/23/2009 | US20090104199 Breast Cancer Resistance Protein (BCRP) And The DNA Which Encodes It |
| 04/23/2009 | US20090104197 vWFA and/or ANT_IG Domain Containing Proteins |
| 04/23/2009 | US20090104196 for modulating the activity of the lysine-specific demethylase (LSD1) in a mammal; for identifying a patient having high risk prostate carcinomas |
| 04/23/2009 | US20090104193 SEMA4D in Cancer Diagnosis, Detection and Treatment |
| 04/23/2009 | US20090104189 Neutrokine-alpha and neutrokine-alpha splice variant |
| 04/23/2009 | US20090104185 Methods and Compositions for Mycoplasma Toxins |
| 04/23/2009 | US20090104182 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 04/23/2009 | US20090104178 Chemokine binding activity of viral tnf receptors and related proteins |
| 04/23/2009 | US20090104177 Peptides for inhibiting the interaction of protein kinase a and protein kinase a anchor proteins |
| 04/23/2009 | US20090104171 Metabolic Enhancement Therapy |
| 04/23/2009 | US20090104170 Compositions and methods for treating hyperproliferative disorders |
| 04/23/2009 | US20090104169 Pet food composition for skin photoprotection |